BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pucci M, Malagolini N, Dall'Olio F. Glycosyltransferase B4GALNT2 as a Predictor of Good Prognosis in Colon Cancer: Lessons from Databases. Int J Mol Sci 2021;22:4331. [PMID: 33919332 DOI: 10.3390/ijms22094331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang M, Sun M, Zhang H. The Interaction Between Epigenetic Changes, EMT, and Exosomes in Predicting Metastasis of Colorectal Cancers (CRC). Front Oncol 2022;12:879848. [DOI: 10.3389/fonc.2022.879848] [Reference Citation Analysis]
2 Stenfelt L, Nilsson J, Hellberg Å, Liew YW, Morrison J, Larson G, Olsson ML. Glycoproteomic and Phenotypic Elucidation of B4GALNT2 Expression Variants in the SID Histo-Blood Group System. Int J Mol Sci 2022;23:3936. [PMID: 35409292 DOI: 10.3390/ijms23073936] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Groux-Degroote S, Vicogne D, Cogez V, Schulz C, Harduin-Lepers A. B4GALNT2 Controls Sda and SLex Antigen Biosynthesis in Healthy and Cancer Human Colon. Chembiochem 2021;22:3381-90. [PMID: 34397142 DOI: 10.1002/cbic.202100363] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Dall'Olio F, Pucci M, Malagolini N. The Cancer-Associated Antigens Sialyl Lewisa/x and Sda: Two Opposite Faces of Terminal Glycosylation. Cancers (Basel) 2021;13:5273. [PMID: 34771437 DOI: 10.3390/cancers13215273] [Reference Citation Analysis]
5 Wavelet-Vermuse C, Groux-Degroote S, Vicogne D, Cogez V, Venturi G, Trinchera M, Brysbaert G, Krzewinski-Recchi MA, Hadj Bachir E, Schulz C, Vincent A, Van Seuningen I, Harduin-Lepers A. Analysis of the proximal promoter of the human colon-specific B4GALNT2 (Sda synthase) gene: B4GALNT2 is transcriptionally regulated by ETS1. Biochim Biophys Acta Gene Regul Mech 2021;1864:194747. [PMID: 34500083 DOI: 10.1016/j.bbagrm.2021.194747] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kim H, Jang H, Cho H, Choi J, Hwang KY, Choi Y, Kim SH, Yang Y. Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy. Cancers (Basel) 2021;13:4435. [PMID: 34503245 DOI: 10.3390/cancers13174435] [Reference Citation Analysis]
7 Qusa MH, Abdelwahed KS, Siddique AB, El Sayed KA. Comparative Gene Signature of (-)-Oleocanthal Formulation Treatments in Heterogeneous Triple Negative Breast Tumor Models: Oncological Therapeutic Target Insights. Nutrients 2021;13:1706. [PMID: 34069906 DOI: 10.3390/nu13051706] [Reference Citation Analysis]